Cusatuzumab

Cusatuzumab Chemische Eigenschaften,Einsatz,Produktion Methoden

Beschreibung

Cusatuzumab is designed as a first-in-class, high-affinity anti-CD70 monoclonal antibody with multiple intended mechanisms of action, including Fc-mediated cytotoxicity with enhanced ADCC and inhibition of CD70/CD27 signaling, resulting in killing of malignant cells such as leukemia blasts and stem cells.

Cusatuzumab Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Cusatuzumab Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
ShangHai Biochempartner Co.,Ltd	17754423994 17754423994	2853530910@QQ.com	China	8017	62
Guangzhou Hongyuan Chemical Co.,Ltd	15817493340	981810490@qq.com	China	1565	58
Wuhan Chemstan Biotechnology Co., Ltd.	027-65317797 15926423062	422450190@qq.com	China	10332	58
AntibodySystem	17762345272 18162686757	biolab-reagents@atagenix.com	China	9819	58
Wuhan Jingkangen Biomedical Technology Co., Ltd	13720134139 13720134139	orders@jknbiochem.com	China	5402	58
Changsha Fuzhen Biotechnology Co.，LTD	0731-18670069 18670069958	184792226@qq.com	China	3195	58

---

• Cusatuzumab
• Research Grade Cusatuzumab(DHE01901)
• Research Grade Cusatuzumab
• 1399546-01-0